NUVB Stock Summary and Trading Ideas (Nuvation Bio Class A | NYSE:NUVB)

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Nuvation Bio Class A trades on the NYSE stock market under the symbol NUVB.

As of July 2, 2026, NUVB stock price climbed to $5.70 with 5,901,406 million shares trading.

NUVB has a beta of 1.49, meaning it tends to be more sensitive to market movements. NUVB has a correlation of 0.04 to the broad based SPY ETF.

NUVB has a market cap of $1.95 billion. This is considered a Small Cap stock.

Last quarter Nuvation Bio Class A reported $83 million in Revenue and $.01 earnings per share. This beat revenue expectation by $15 million and missed earnings estimates by -$.05.

In the last 3 years, NUVB traded as high as $9.75 and as low as $.95.

The top ETF exchange traded funds that NUVB belongs to (by Net Assets): VTI, IWM, VXF, IWO, IBB.

NUVB has outperformed the market in the last year with a price return of +178.0% while the SPY ETF gained +21.3%. NUVB has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +29.3% and +2.5%, respectively, while the SPY returned +13.9% and -0.3%, respectively.

NUVB support price is $5.12 and resistance is $5.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NUVB shares will trade within this expected range on the day.